Based on the demonstrated potential of laser-induced vapor nanobubbles to treat bacterial biofilm infections, we provide recommendations for future work in order to further mature this new technology into a promising anti-biofilm approach.
Scientists have created the world’s first living organism that has a synthetic and altered genetic code, built on only 61 codons as opposed to 64.
A new anaerobic organ-on-a-chip model has been demonstrated to support a complex community of gut microbes under low-oxygen conditions. This model of the microbiome could open opportunities for drug testing and development.
Take a look behind the scenes of a recent Future Microbiology review, entitled: ‘Pathogen-associated acute encephalitis syndrome: therapeutics and management’, as we ask the authors about the challenges facing this field, the use of complementary and alternative medicine and what research needs to be done.
Antibiotic tolerance significantly reduces antibiotic efficacy and contributes to treatment failure; targeting both antibiotic tolerance and antibiotic resistance is critical to develop new antimicrobial strategies that will successfully eradicate hard-to-treat infections.
New research has suggested that a combination treatment of gentamicin with azithromycin was almost as effective as the currently used ceftriaxone for treating genital gonorrhea.
Take a look behind the scenes of a recent Future Virology review, entitled: ‘Comparative host genomics: Has recent human evolution affected our immune defense against hepatitis C virus?’, as we ask the authors about the importance of the IFNL4 gene and the work that’s still to be done in the field.
Take a look at this month’s industry headlines including news from ViiV Healthcare on long-acting and single dose formulations, sales for Eli Lilly and the possible development of a plague vaccine.
Men and women have different risks of developing surgical site infections depending on the type of operation they undergo, according to new research being presented at ECCMID.
Research presented at ECCMID examining influenza transmission has discovered that a substantial proportion of patients and healthcare workers shed the flu virus before clinical symptoms appear.
